BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24291232)

  • 1. β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells.
    Ye X; Wu F; Wu C; Wang P; Jung K; Gopal K; Ma Y; Li L; Lai R
    Cell Signal; 2014 Mar; 26(3):492-501. PubMed ID: 24291232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer.
    Alqahtani H; Gopal K; Gupta N; Jung K; Alshareef A; Ye X; Wu F; Li L; Lai R
    Cell Signal; 2016 Feb; 28(2):42-50. PubMed ID: 26569340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.
    Jung K; Wang P; Gupta N; Gopal K; Wu F; Ye X; Alshareef A; Bigras G; McMullen TP; Abdulkarim BS; Lai R
    Breast Cancer Res; 2014 Nov; 16(6):470. PubMed ID: 25380620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.
    Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R
    BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporter.
    Gopal K; Gupta N; Zhang H; Alshareef A; Alqahtani H; Bigras G; Lewis J; Douglas D; Kneteman N; Lavasanifar A; Lai R
    Oncotarget; 2016 Jan; 7(3):3111-27. PubMed ID: 26683522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma.
    Wu C; Zhang HF; Gupta N; Alshareef A; Wang Q; Huang YH; Lewis JT; Douglas DN; Kneteman NM; Lai R
    J Hematol Oncol; 2016 Nov; 9(1):120. PubMed ID: 27821172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity.
    Wu F; Zhang J; Wang P; Ye X; Jung K; Bone KM; Pearson JD; Ingham RJ; McMullen TP; Ma Y; Lai R
    Cell Signal; 2012 Nov; 24(11):1989-98. PubMed ID: 22800865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity.
    Wu F; Ye X; Wang P; Jung K; Wu C; Douglas D; Kneteman N; Bigras G; Ma Y; Lai R
    BMC Cancer; 2013 Jul; 13():317. PubMed ID: 23815808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
    BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
    Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
    Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of human breast cancer cells with SOX2 promoter activity.
    Liang S; Furuhashi M; Nakane R; Nakazawa S; Goudarzi H; Hamada J; Iizasa H
    Biochem Biophys Res Commun; 2013 Jul; 437(2):205-11. PubMed ID: 23796710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3, a novel binding partner of beta-catenin.
    Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
    Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter.
    Jung K; Gupta N; Wang P; Lewis JT; Gopal K; Wu F; Ye X; Alshareef A; Abdulkarim BS; Douglas DN; Kneteman NM; Lai R
    Oncotarget; 2015 Apr; 6(12):10366-73. PubMed ID: 25868977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma.
    Alshareef A; Gupta N; Zhang HF; Wu C; Haque M; Lai R
    Sci Rep; 2017 Dec; 7(1):16863. PubMed ID: 29203817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NONO Is a Negative Regulator of
    Liang S; Takahashi H; Hirose T; Kuramitsu Y; Hatakeyama S; Yoshiyama H; Wang R; Hamada JI; Iizasa H
    Cancer Genomics Proteomics; 2020; 17(4):359-367. PubMed ID: 32576581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
    Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
    Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.